Home > Income Statement > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Revenue

    Back to Income Statement
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

MOREPEN LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,812 Cr₹1,690 Cr₹1,418 Cr₹1,547 Cr₹1,188 Cr

What is the latest Revenue of MOREPEN LABORATORIES ?

The latest Revenue ratio of MOREPEN LABORATORIES is ₹1,812 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,812 Cr
Mar2024₹1,690 Cr
Mar2023₹1,418 Cr
Mar2022₹1,547 Cr
Mar2021₹1,188 Cr

How is Revenue of MOREPEN LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹1,812 Cr
7.17
Mar2024 ₹1,690 Cr
19.25
Mar2023 ₹1,418 Cr
-8.36
Mar2022 ₹1,547 Cr
30.20
Mar2021 ₹1,188 Cr -

Compare Revenue of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹2,154.2 Cr 3.6% 10.5% -27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

3.6%

10.5%

-27.1%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses